Leidos Holdings, Inc. $LDOS Shares Purchased by QRG Capital Management Inc.

QRG Capital Management Inc. raised its stake in Leidos Holdings, Inc. (NYSE:LDOS) by 31.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,411 shares of the aerospace company’s stock after acquiring an additional 6,963 shares during the period. QRG Capital Management Inc.’s holdings in Leidos were worth $4,574,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of LDOS. Counterpoint Mutual Funds LLC acquired a new stake in shares of Leidos during the first quarter worth about $4,209,000. New York State Teachers Retirement System boosted its position in shares of Leidos by 1.2% in the 1st quarter. New York State Teachers Retirement System now owns 125,537 shares of the aerospace company’s stock valued at $19,524,000 after purchasing an additional 1,432 shares during the period. Y Intercept Hong Kong Ltd boosted its position in shares of Leidos by 503.7% in the 1st quarter. Y Intercept Hong Kong Ltd now owns 35,298 shares of the aerospace company’s stock valued at $5,490,000 after purchasing an additional 29,451 shares during the period. Leonteq Securities AG grew its stake in Leidos by 5.0% during the 1st quarter. Leonteq Securities AG now owns 5,358 shares of the aerospace company’s stock worth $833,000 after buying an additional 256 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC purchased a new position in Leidos during the 1st quarter worth approximately $527,000. Institutional investors and hedge funds own 76.12% of the company’s stock.

Leidos Stock Performance

NYSE:LDOS opened at $108.58 on Monday. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.40 and a quick ratio of 1.29. The firm has a market cap of $13.66 billion, a price-to-earnings ratio of 9.94, a price-to-earnings-growth ratio of 1.60 and a beta of 0.54. The firm’s fifty day moving average price is $122.85 and its 200 day moving average price is $157.43. Leidos Holdings, Inc. has a 1-year low of $98.86 and a 1-year high of $205.77.

Leidos (NYSE:LDOS) last announced its quarterly earnings data on Tuesday, May 5th. The aerospace company reported $3.13 EPS for the quarter, topping analysts’ consensus estimates of $2.88 by $0.25. The company had revenue of $4.40 billion during the quarter, compared to the consensus estimate of $4.28 billion. Leidos had a net margin of 8.15% and a return on equity of 31.92%. Leidos’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.97 EPS. Leidos has set its FY 2026 guidance at 12.100-12.500 EPS. On average, sell-side analysts expect that Leidos Holdings, Inc. will post 12.26 EPS for the current year.

Leidos Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th were issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend was Monday, June 15th. Leidos’s payout ratio is currently 15.75%.

Insider Activity at Leidos

In related news, insider Elizabeth A. Porter sold 2,000 shares of Leidos stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of $158.78, for a total value of $317,560.00. Following the sale, the insider directly owned 49,476 shares in the company, valued at $7,855,799.28. The trade was a 3.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Stephen May sold 1,484 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $132.75, for a total value of $197,001.00. Following the transaction, the director directly owned 10,137 shares in the company, valued at $1,345,686.75. This represents a 12.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.77% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Citigroup reduced their price objective on Leidos from $178.00 to $138.00 and set a “buy” rating for the company in a research note on Wednesday, July 1st. Jefferies Financial Group lowered their target price on shares of Leidos from $140.00 to $110.00 and set a “hold” rating on the stock in a research report on Wednesday. Wall Street Zen raised shares of Leidos from a “hold” rating to a “buy” rating in a report on Tuesday, June 30th. Truist Financial reduced their price target on shares of Leidos from $220.00 to $195.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Finally, Wells Fargo & Company set a $125.00 price target on shares of Leidos in a research note on Wednesday, June 17th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, Leidos has an average rating of “Moderate Buy” and an average target price of $172.08.

Leidos Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.